Transthyretin (TTR) familial amyloid polyneuropathies (FAP) are autosomal dominant ow epending on ed. In Europe, northern Sweden is the second most important area of the disease, and a late age of onset ish families.
Introduction
Transthyretin (TTR) amyloid neuropathy is the most severe neuropathy of adulthood with acellular deposition of the ATTR hy with autonomic manifestations frequently associated to cardiac dysfunction. Other manifestations include, ocular symptoms related to vitreous amyloidosis and eventually renal failure. A fatal outcome occurs after an average duration of 10 -13 years [1, 2] . By removing the main source of mutated TTR, liver transplantation is the only therapeutic approach available, a de Varzim where the prevalence is 1/1000, the condition was subsequently recognized throughout the world including various European countries and two different foci in Japan [6, 7] . Apart from Portugal, the most important focus of the disease in Europe takes place in the north of Sweden where families are mainly clustered in limited areas around the towns of Skellefteå st common pathogenic variant and virtually the only one described in Portugal and Sweden [9] .
Genotype phenotype correlations are unclear. Moreover, phenotypic variations and striking differences in the age of onset are observed between populations of Val30Met patients.
Hence, the mean age of first symptoms is 33 years in Portugal and in the main endemic of age [11] .
ld explain the higher age of onset in Sweden.
In Sweden, a population study had suggested that disease risk in carrier individuals could be rather low [11] . The age of onset is variable among pedigrees and is significantly higher with paternal inheritance compared with that of maternal inheritance [12] . This finding needs to be autosomal dominant transmission. The disease is characterised by extr amyloid made up of mutated TTR, of which the most common mutation is Val30Met. Its main clinical expression is a progressive sensory-motor neuropat which can stabilize the disease when performed early in the course [3, 4] .
Initially reported by Andrade (1952) in northern Portugal [5] in the area of Povo and Piteå [8] .
Among 100 point mutations identified in the TTR gene, the Val30Met is by far the mo areas in Japan, [7, 10] whereas in Sweden, the onset is rather late, at 56 years Screenings have not disclosed any protective variant of the TTR gene that cou 3 inserm-00359758, version 1 -9 Feb 2009 confirmed by estimating the penetrance (cumulative risk of being affected by a given age) in mutation carriers, i.e. the risk that a carrier individual be affected given (s)he has reached a given age.
ias toward affected ed [13] .
The aim of the study was to assess the penetrance of Swedish TTR-Val30Met, using a biasfree method and to disclose differences in penetrance within the endemic area. In addition, to estimate the impact of transmitting parents' gender on age at onset of the disease.
Patients and Methods

Among the 401 patients treated at the Department of Clinical Genetics Umeå
University Hospital, since 1986 and identified with a Val30Met mutation, a complete ere related t could enter the is. Eight pedigrees contained 9 homozygous patients for the Val30Met mutation, and wer liable estimation vailable for penetrance analysis.
In patients, the diagnosis of TTR amyloid neuropathy was based on the finding of deposits were not always immunohistochemically diagnoses as TTR-amyloid. The pathogenic TTR variant Val30Met mutation were identified by molecular genetic testing in all cases.
Genealogical investigation was carried out for all patients when possible since 1999 and data were entered using Cyrillic software (version 2.0). 
Genetic analysis
TR-Val30Met mutation. At first sed to analyse the patients. Later they were diagnosed by polymerase d methods as previously described [11, 14] . Briefly, the age-dependent penetrance function for mutation carriers was modelled by a Weibull distribution, defined by three parameters: λ (scale parameter), a (shape parameter) and κ, the fraction of individuals that would never be affected [16] . The penetrance function may be written:
For the present study, a total of 1353 subjects were recorded and cli was obtained on 235 affected individuals, including the probands. Overall, DNA was performed in 215 individuals of the families. Among them 49 were asympto carriers.
Over time different methods have been used to detect the T Southern blot were u chain reaction (PCR) base
mation of penetrance
We used the same method as Planté-Bordeneuve et al. [15] which for ascertainment bias when using family data. The method is bas ihood principle, using a survival analysis approach. Beside the correction fo ascertainment, its main interest is to use phenotypic information on individuals w genotype is unknown but whose probability of being a carrier is not negligible
Following survival analysis principles, the contribution of pedigree members to the likelihood depends on respectively the age at diagnosis for affected and the age at last news (or at death) for unaffected relatives. observed allele in the general population assuming Hardy-Weinberg equilibrium for a founder (parents' status unknown). Otherwise, this probability depends on parental genotypes assuming Mendelian transmission. In this analysis, disease allele frequency was estimated using the proportion of homozygotes among all affected individuals in the population, as explained in the appendix. On the basis of the known age of onset in previous reports of TTR amyloid neuropathy in Sweden, individuals younger than 18 years were not considered in the present study [8, 11, 12] .
Ethics. The project has been approved by the Ethic Committee at Umea University The probability of unknown genotypes of untested individuals given genotypes in the families was computed from the frequency of the mutated For sake of simplicity, the probability of being homozygous was negl reasons given above.
To test for a dif smitting parent, we used a likelihood ratio test.
All family data providing information on the risk of being affected for 
At a ectively. Even
When subdividing the sample according to the three regions, the Lycksele was too small to allow a valid estimate (10 families), thus, only Piteå and Skellefteå were compared.
As shown in figure 2, the penetrance was significantly lower for the Piteå region than for the Skellefteå region, with penetrance by age 80 of 32% and 65% respectively. The homogeneity 2 und ( figure 3 ).
Among the 77 families, the gender of the transmitting parent was known for 762 individuals:
for 435 the transmitting parent was the mother, and for 327 the transmitting parent was the father. The penetrance was found to be significantly higher when the mutation was inherited from the mother than from the father (χ 2 = 7.84, 2 df, p < 0.02). Table 2 shows the penetrance estimates and confidence intervals according to the sex of the transmitting parent.
Discussion patients, the frequency of this mutation was es was fixed at this value in all subsequent analyses. Figure 1 shows the penetrance curves for the whole sample and f 2 a estimated. The risks and confidence intervals from age 30 to ge 30 and 60 years, the penetrance estimates were 1.7% and 22%, resp by age 90 years, penetrance was found to be far from complete (69%).
test was highly significant (χ = 26.60, 2 df, p < 0.001).
A The patients were all recruited from the Department of Medicine, Umeå
Hospital. This is a referral centre for FAP in Sweden. However, patients w material has a bias against younger patients, and to some degree patients w progressing disease. Moreover, marked differences in penetrance of the trait w within the endemic area. Such differences might be due to genetic factors ( has been shown to be robust to a variation in this parameter [13] . Differences in reported prevalence could in part be due to an underestimation of affected individuals as probably is
The other remarkable finding is the marked differences of penetranc the gender of the transmitting parent. Indeed, the penetrance of the trait wa (higher penetrance in younger generations) was more marked in descen mothers [12] . Differences of age of onset according to the gender of the transmi have also been mentioned in Japanese and Portuguese families but such v penetrance has not been precisely analysed in other populations [10, 21] . It is might be interest the mitochondrial genome interacting with the expression or the pathogenesis Val30Met mutation.
healthy volunteers from the endemic area and the known number of affected in
The difference between the penetrance estimates cannot be due to an asce since our method takes into account that families without any affected individu 9 inserm-00359758, version 1 -9 Feb 2009 the case in the previous Swedish study, since it did not adjust for age. Indeed, the affected individuals were mostly older than 60 years, whereas those in the reference population were much younger. 
